Megan M. Abbott, MD, MPH

Hometown: Litchfield, Maine
Undergraduate: Boston University (Biology)
Medical school: Harvard Medical School
Graduate School: Harvard School of Public Health, M.P.H.
Research interests: Costing in health care, value-based health care, quality/outcomes, health care policy, payment reform
Nasoalveolar molding in cleft care: is it efficacious? Abbott MM, Meara JG. Plast Reconstr Surg.  2012: in press.

Measuring value at the provider level in the management of cleft lip and palate patients.  Abbott MM, Rosen H, Kupfer P, Meara JG.  Ann Plast Surg.  2012; in press.

Cost differences between the anterior and posterior approaches to the iliac crest for alveolar bone grafting in patients with cleft lip/palate. Kupfer P, Abbott MM, Abramowicz S, Meara JG, Padwa BL. J Oral Maxillofac Surg.  2012; 70:685-689.

The cost of treating sagittal synostosis in the first year of life: Endoscopically-assisted suturectomy and postoperative helmet therapy vs. open cranial vault remodeling. Abbott MM, Rogers GF, Proctor MR, Busa K, Meara JG. J Craniofac Surg. 2012; 23:88-93.

Patient Protection and Affordable Care Act: Implications for pediatric plastic surgery.  Abbott MM, Meara JG.  J Craniofac Surg. 2012;23:1-3.

Timeliness of surgical care in children with special health care needs: delayed palate repair for publicly insured and minority children with cleft palate.  Abbott MM, Kokorowski PJ, Meara JG.  J Pediatric Surg.  2011;46:1319-1324.

Accountable care organizations: a primer for surgeons. Ganske I, Abbott MM, Meara J. Bull Am Coll Surg.  2011;96:27-35.

Surgeons, other providers take the lead on integrating health care services. Abbott MM, Nguyen V, Meara JG. Bull Am Coll Surg. 2011;96:14-19.

The value proposition: utilizing a cost improvement map to improve value for patients with non-syndromic, isolated cleft palate. Abbott MM, Alkire BC, Meara JG. Plast Reconstr Surg.  2011;127:1650-1658.

A microcosting approach for isolated, unilateral cleft lip care in the first year of life. Abbott, MM, Meara, JG. Plast Reconstr Surg.  2011;127:333-339.

Marginal zone B-cell lymphoma of the infratemporal fossa: A rare case and review.  Abbott, MM, Hasserjian RP, Emerick KS.  Laryngoscope.  2010;120:2430-2433.

Value-based cleft lip-cleft palate care: a progress report. Abbott MM, Meara JG. Plast Reconstr Surg. 2010;126:1020-1025.

Non-Fc-mediated mechanisms are involved in clearance of amyloid-beta in vivo by immunotherapy. Bacskai BJ, Kajdasz ST, McLellan ME, Games D, Seubert P, Schenk D, Hyman BT. J Neurosci. 2002;22:7873-7878.

In Vivo Multiphoton Imaging of a Transgenic Mouse Model of Alzheimer’s Disease Reveals Marked Thioflavine-S Associated Alterations in Neurite Trajectories. D’Amore JD, Kajdasz ST, McLellan ME, Bacskai BJ, Stern EA, Hyman BT. J Neuropathol Exp Neurol. 2003;62:137-145.

Estrogen and xenoestrogens upregulate the brain aromatase isoform (P450aromB) and perturb markers of early development in zebrafish (Danio rerio). Kishida M, McLellan ME, Miranda JA, Callard GV. Comp Biochem Physiol B Biochem Mol Biol. 2001;129:261-268.

Imaging Abeta plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative. Klunk WE, Bacskai BJ, Mathis CA, Kajdasz ST, McLellan ME, Frosch MP, Debnath ML, Holt DP, Wang Y, Hyman BT. J Neuropathol Exp Neurol. 2002;61:797-805.

Amyloid-beta antibody treatment leads to rapid normalization of plaque-induced neuritic alterations. Lombardo JA, Stern EA, McLellan ME, Kajdasz ST, Hickey GA, Bacskai BJ, Hyman BT. J Neurosci. 2003;23:10879-10883.

A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain. Bioorg Med Chem Lett. Mathis CE, Bacskai BJ, Kajdasz ST, McLellan ME, Frosch MP, Hyman BT, Holt DP, Wang Y, Huang GF, Debnath ML, KlunkWE. 2002;12:295-298.

In vivo imaging of reactive oxygen species specifically associated with thioflavine S-positive amyloid plaques by multiphoton microscopy. McLellan ME, Kajdasz ST, Hyman BT, Bacskai BJ. J. Neurosci. 2003;23:2212-2217.

Lopinavir/ritonavir (LPV/r) + two nucleoside analogues as second-line ART in protease-inhibitor naïve adults in South Africa: outcomes and adverse effects. Murphy RA, Sunpath H, Nijhawan A, McLellan ME, Kuritzkes DR. As presented at The 15th Annual Conference on Retroviruses and Opportunistic Infections (CROI) Boston, MA: Feb. 3-5, 2008.